Clinical trial

HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006)

NCT07441889

Study summary

ClinicalTrials.gov

HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006)

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE1, PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention HER2 FPBMC Find medicine records · Find other trials using this name

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-06-01

PhasePHASE1 / PHASE2

Conditions

Breast Cancerverified · MONDO: breast cancer

Prostate Cancerverified · MONDO: prostate cancer

Interventions

HER2 FPBMCDRUG

Sponsors & collaborators

University of Virginialead sponsor

Mapped research locations

CharlottesvilleVirginia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07441889 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.